FDA Approval Summary: Sonidegib-Letter

Clin Cancer Res. 2017 Oct 1;23(19):5993. doi: 10.1158/1078-0432.CCR-17-1460.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biphenyl Compounds
  • Carcinoma, Basal Cell*
  • Humans
  • Pyridines
  • Skin Neoplasms*

Substances

  • Biphenyl Compounds
  • Pyridines
  • sonidegib